ELIGARD 45 mg, poudre et solvant pour solution injectable
UC-0160/1003
Phase 3 small_molecule active
Quick answer
ELIGARD 45 mg, poudre et solvant pour solution injectable for Prostatic adenocarnicoma with high risk of recurrence is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Prostatic adenocarnicoma with high risk of recurrence
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active